1. Home
  2. GTN vs PRTC Comparison

GTN vs PRTC Comparison

Compare GTN & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GTN

Gray Television Inc.

HOLD

Current Price

$4.05

Market Cap

432.5M

Sector

Industrials

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

HOLD

Current Price

$17.42

Market Cap

423.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTN
PRTC
Founded
1897
2015
Country
United States
United States
Employees
9582
56
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
432.5M
423.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GTN
PRTC
Price
$4.05
$17.42
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
1.2M
4.7K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
5.79%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.89
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.72
$8.09
Revenue Growth
N/A
N/A
52 Week Low
$3.50
$14.50
52 Week High
$6.44
$19.92

Technical Indicators

Market Signals
Indicator
GTN
PRTC
Relative Strength Index (RSI) 42.42 51.72
Support Level $3.83 $16.67
Resistance Level $4.27 $18.70
Average True Range (ATR) 0.15 0.76
MACD 0.05 -0.04
Stochastic Oscillator 58.43 30.55

Price Performance

Historical Comparison
GTN
PRTC

About GTN Gray Television Inc.

Gray Media Inc is a multimedia company. The company owns and operates local television stations and digital assets. It also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with digital products and services. Its additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios. The company's segments include Broadcasting and Production Companies. The majority of revenue is derived from broadcast and digital advertising and from retransmission consent fees.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: